1. Home
  2. CPB vs MMED Comparison

CPB vs MMED Comparison

Compare CPB & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$22.85

Market Cap

6.6B

ML Signal

HOLD

Logo MiniMed Group Inc. Common Stock

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$19.53

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPB
MMED
Founded
1869
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
5.5B
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
CPB
MMED
Price
$22.85
$19.53
Analyst Decision
Hold
Strong Buy
Analyst Count
18
10
Target Price
$26.06
$22.56
AVG Volume (30 Days)
5.1M
1.1M
Earning Date
06-01-2026
06-03-2026
Dividend Yield
7.63%
N/A
EPS Growth
6.35
N/A
EPS
1.55
N/A
Revenue
$10,253,000,000.00
$3,102,000,000.00
Revenue This Year
N/A
$15.99
Revenue Next Year
$0.11
$10.00
P/E Ratio
$14.65
N/A
Revenue Growth
6.40
14.25
52 Week Low
$19.56
$10.65
52 Week High
$34.18
$20.88

Technical Indicators

Market Signals
Indicator
CPB
MMED
Relative Strength Index (RSI) 53.54 63.46
Support Level $19.93 $10.68
Resistance Level $23.45 N/A
Average True Range (ATR) 0.56 0.84
MACD 0.02 -0.02
Stochastic Oscillator 70.75 63.66

Price Performance

Historical Comparison
CPB
MMED

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: